��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2002, 28(4) 231-233 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��
	��ϸ��
	��
	��
	��
	֣־��
	PubMed
	Article by
	Article by

��ϸ��ڰ��е��

��, ֣־��

��ѧ��ɽҽԺƤ�� Ϻ� 200040

ժҪ��

�йذ��粡��ĸ��ѧ˵��ѧ˵�õ��Խ��Խ��ӡ��о��ְ��Ƥ��к��ϸ��ƻ��ʧ�뻼�ߵ��Һ��ϸ��ء��ϸ��ںϳɺ��ص�ͬʱ��߹��,��п��ƻ��һ��á�

�ؼ���� ϸ��

Abstract:

Keywords:

�ո�� 2001-11-01 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Kovacs SO.Vitiligo.J Am Acad Dermatol,1998,38(5 Pt 1):647-666.
[2] Nishimura EK,Yoshida H,Kunisada T,et al.Regulation of E-and P-cadherin expression correlated with melanocyte migration and diversification.Dev Biol,1999,215(2):155-166.
[3] Ardic FN,Aktan S,Kara CO,et al.High-frequency hearing and reflex latency in patients with pigment disorder.Am J Otolaryngol,1998,19(6):365-369.
[4] Kobayashi N,Nakagawa A,Muramatsu T,et al.Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis.J Invest Dermatol,1998,110(5):806-810.
[5] Lim HW,Cooper K.The health impact of solar radiation and prevention strategies:Report of the Environment Council,American Academy of Dermatology.J Am Acad Dermatol,1999,41(1):81-99.
[6] Hearing VJ.Biochemical control of melanogenesis and melanosomal organization.J Investig Dermatol Symp Proc,1999,4(1):24-28.
[7] Le Poole IC,Mutis T,van den Wijngaard RM,et al.A novel,antigenpresenting function of melanocytes and its possible relationship to hypopigmentary disorders.J Immunol,1993,151(12):7284-7292.
[8] Le Poole IC,van den Wijngaard RM,Westerhof W,et al.Phagocytosis by normal human melanocytes in vitro.Exp Cell Res,1993,205(2):388-395.
[9] McCoy KD,Le Gros G.The role of CTLA-4 in the regulation of T cell immune responses.Immunol Cell Biol,1999,77(1):i-10.
[10] Kemp EH,Ajjan RA,Waterman EA,et al.Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.Br J Dermatol,1999,140(1):73-78.
[11] Overwijk WW,Lee DS,Surman DR,et al.Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice:requirement for CD4(+) T lymphocytes.Proc Natl Acad Sci USA,1999,96(6):2982-2987.
[12] Gilhar A,Zelickson B,Ulman Y,et al.In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo.J Invest Dermatol,1995,105(5):683-686.
[13] van den Wijngaard R,Wankowicz-Kalinska A,Le Poole C,et al.Local immune response in skin of generalized vitiligo patients.Destruction of melanocytes is associated with the prominent presence of CLA⁺ T cells at the perilesional site.Lab Invest,2000,80(8):1299-1309.
[14] Rivoltini L,Badrizzani M,Accomero P,et al.Human melanoma-reactive CD4⁺ and CD8⁺ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.J Immunol,1998,161(3):1220-1230.
[15] Rosenberg SA.Cancer vaccines based on the identification of genes encoding cancer regression antigens.Immunol Today,1997,18(4):175-182.
[16] Ogg GS,Rod Dunbar P,Romero P,et al.High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.J Exp Med,1998,188(6):1203-1208.
[17] Pittet MJ,Valmori D,Dunbar PR,et al.High frequencies of naive MelanA/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen(HLA)-A2 individuals.J Exp Med,1999,190(5):705-715.
[18] Yee C,Thompson JA,Roche P,et al.Melanocyte destruction after antigen-specific immunotherapy of melanoma:direct evidence of t cell-mediated vitiligo.J Exp Med,2000,192(11):1637-1644.
[19] Zarour HM,Kirkwood JM,Kierstead LS,et al.Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-reatricted epitope recognized by melanoma-reactive CD4⁺T cells.Proc Natl Acad Sci U S A,2000,97(1):400-405.
[20] Das PK,van den Wijngaard RM,Wankowicz-Kalinska A,et al.A symbiotic concept of autoimmunity and tumour immunity:lessons from vitiligo.Trends Immunol,2001,22(3):130-136.
[21] Wang S,Bartido S,Yang G,et al.A role for a melanosome transport sigral in accessing the MHC class �� presentation pathway and in eliciting CD4⁺T cell responses.J Immunol,1999,163(11):5820-5826.
[22] Krutmann J,Morita A.Mechanisms of ultraviolet(UV) B and UVA phototherapy.J Investig Dermatol Symp Proc,1999,4(1):70-72.

��е��

1��ΰ,��.��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 222-

2��,��ѧ��.��ػ��о��ع�[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 219-

3��,��ٺ�,֣־��.308 nm׼��Ӽ��ư��״[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 150-

4��.խ��UVB311��UVB��ÿ��ư��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 161-

5��, ��.��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 355-357

6��Ҧ�ܲ�.��±��/��ư��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(2): 77-77

7��,��.��Ƥ��зǺ��ϸ��չ[J]. ��Ƥ��Բ�ѧ��־, 2008,34(3): 178-180

8��,��.��ͯ��ٴ��ѧ�о�[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 211-214

9��ѧ��,ξ��,��.��Ƥϸ��Һ��ֲ��ư��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 238-240

10��,ξ��,��.��縺ѹ��Ƥ��ֲ��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(5): 305-307

11��zhuwu,��.��综�ߵ��ط��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(5): 338-339